As we bid farewell to 2024, Jubilant HollisterStier is proud to celebrate a year defined by remarkable achievements, impactful collaborations, and a steadfast commitment to shaping the future of pharmaceutical manufacturing. Here’s a look back at some of the highlights that made this year so extraordinary. 

Expanding Our Capabilities 

This year marked a major milestone in our ongoing growth with the completion of our state-of-the-art expansion project in Spokane, Washington. Our third production line, equipped with cutting-edge isolator technology, became fully operational in early 2024, allowing us to scale our manufacturing capacity significantly. Line 3 created 200 new jobs in Spokane, with another 200 to come as work progresses on Line 4, set to launch next year. 

Industry Recognition 

Our commitment to excellence was recognized when we were named the Association of Washington Business’s 2024 Manufacturer of the Year. This prestigious award honors our dedication to business excellence, innovation, and community engagement. We’re grateful to our incredible team, whose hard work and passion drive our continued success. 

Leading Through Industry Trends 

2024 saw an increasing demand for sterile fill-finish solutions and lyophilization services, with a sharp focus on regulatory compliance and supply chain reliability. Jubilant HollisterStier remained ahead of these trends, delivering quality-driven solutions while maintaining rapid response times and innovative project management. 

Making a Difference in Our Community 

At Jubilant HollisterStier, we believe that success is measured not only by industry milestones but also by the impact we have on our community. 

This year, we proudly participated in several local initiatives, including the Teddy Bear Toss in partnership with the Spokane Chiefs hockey team, where thousands of teddy bears were collected and donated to children in need. Additionally, we contributed to programs like Toys for Tots and local backpack donation drives, providing resources and support to families in the Spokane area. 

These efforts reflect our commitment to giving back and fostering a stronger, healthier community for all. 

Looking Ahead to 2025 

As we reflect on this year, we’re more energized than ever for the opportunities ahead. With Line 4 nearing completion and a continued focus on innovation, sustainability, and excellence, we look forward to setting even higher standards in pharmaceutical manufacturing in 2025. 

To our clients, partners, and employees: Thank you for your trust, collaboration, and commitment. Together, we’re building a healthier tomorrow. 

Here’s to a successful and impactful 2025! 

The Jubilant HollisterStier Team 

Additional References
  1. Olena Chervonenko, and Gerardo Gomez. “Keys to Successful Technology Transfer.” Bioprocessintl.com, 12 June 2024, www.bioprocessintl.com/information-technology/keys-to-successful-technology-transfer. Accessed 20 Sept. 2024.
  2. “Tech Transfer: Unraveling the Complexities – BioProcess International.” Www.bioprocessintl.com, www.bioprocessintl.com/contract-services/unraveling-the-complexities-of-technology-transfer. 
  3. Zhang, Mingming. “Pilot-Scale Studies, Scaling-Up, and Technology Transfer.” Springer EBooks, 20 Oct. 2022, pp. 161–167, https://doi.org/10.1007/978-3-031-10102-1_9. 

Related Posts